EGFR and breast cancer: A previous study demonstrated that mTOR kinase inhibition of breast cancer cells for 24 h led to inhibition of pAkt S473 but activation of pAkt T308, along with downstream effectors of Akt, because of activation of several RTKs, including ERBB family members as well as IGF1R and IR.